Clinical Trials Browser

Not yet recruiting × Letrozole × 1 year × Clear all

NCT07389733 2026-03-02

A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer

Phase 1/2 Not yet recruiting

Advanced Unresectable or Metastatic Breast Cancer of Adults

NCT07394946 2026-02-20

NELOPHER

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07379502 2026-01-30

Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

Phase NA Not yet recruiting

Polycystic Ovary Syndrome

NCT07340658 2026-01-14

SIE-3

Phase 3 Not yet recruiting

Breast Neoplasms

NCT07305246 2025-12-26

Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07101159 2025-08-03

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

Phase 2 Not yet recruiting

Breast Neoplasms

NCT06223698 2025-04-20

SWE-Switch

Phase 3 Not yet recruiting

Breast Neoplasms

NCT06861803 2025-03-21

Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients

Not yet recruiting

Polycystic Ovary Syndrome